Introduction and Objective: Use of insulin pumps and continuous glucose monitors (CGM) can cause dermatological complications which may vary by gender and race. We sought to assess the prevalence of skin reactions among different genders and races.Methods: Youth and young adults (2-25 years) with T1D wearing a diabetes device were invited to complete a survey assessing the presence of device-related skin reactions. Participants were classified based on gender (female, male, other) and self-reported race as non-Hispanic white (NHW) or nonwhite.Results: 88 participants enrolled (mean age 15.4 ± 6.2yrs, 59.1% female, mean HbA1c 7.0±1.0%). 88% identified as NHW. There were no significant differences in the presence of skin reactions between gender (p = 1) or race (p = 0.085).Conclusion: Device-related skin reactions are common but do not differ between gender or race. Greater representation from non-white participants is underway to fully evaluate the prevalence of device-related skin reactions.
V.S. Fadhel Hernández: None. A.J. Karami: None. C. Sakamoto: None. K. Taylor: None. E. Fivekiller: None. C. Berget: Consultant; Insulet Corporation. Advisory Panel; Tandem Diabetes Care, Inc. Other Relationship; Tandem Diabetes Care, Inc, Insulet Corporation, embecta. S. Lange: Advisory Panel; Medtronic. E.C. Cobry: Advisory Panel; Dexcom, Inc.
NIDDK (2T32DK063687)
Source link
Leave a Reply